These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25822339)

  • 1. Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma.
    Puzio-Kuter AM; Laddha SV; Castillo-Martin M; Sun Y; Cordon-Cardo C; Chan CS; Levine AJ
    Cell Death Differ; 2015 Nov; 22(11):1785-91. PubMed ID: 25822339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status.
    Ou WB; Zhu J; Eilers G; Li X; Kuang Y; Liu L; Mariño-Enríquez A; Yan Z; Li H; Meng F; Zhou H; Sheng Q; Fletcher JA
    Oncotarget; 2015 Apr; 6(12):10510-20. PubMed ID: 25888633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
    Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
    J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
    Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A
    Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.
    Kato S; Schwaederle M; Daniels GA; Piccioni D; Kesari S; Bazhenova L; Shimabukuro K; Parker BA; Fanta P; Kurzrock R
    Cell Cycle; 2015; 14(8):1252-9. PubMed ID: 25695927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
    Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
    Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
    Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective elimination of amplified CDK4 sequences correlates with spontaneous adipocytic differentiation in liposarcoma.
    Hélias-Rodzewicz Z; Pédeutour F; Coindre JM; Terrier P; Aurias A
    Genes Chromosomes Cancer; 2009 Nov; 48(11):943-52. PubMed ID: 19626636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
    Louis-Brennetot C; Coindre JM; Ferreira C; Pérot G; Terrier P; Aurias A
    Genes Chromosomes Cancer; 2011 Nov; 50(11):896-907. PubMed ID: 21910158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
    Boltze C; Schneider-Stock R; Jäger V; Roessner A
    Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
    Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Well-differentiated liposarcoma associated with benign lipoma.
    Hatano H; Morita T; Ogose A; Hotta T; Kobayashi H; Honma K
    Anticancer Res; 2004; 24(2C):1039-44. PubMed ID: 15154619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
    Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
    Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
    Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on liposarcoma: a review for cytopathologists.
    Dodd LG
    Diagn Cytopathol; 2012 Dec; 40(12):1122-31. PubMed ID: 21932353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Hirose T; Endo N
    Pathol Int; 2011 Aug; 61(8):461-8. PubMed ID: 21790860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.